Skip to main content
Heranba Industries Limited logo

Heranba Industries Limited — Investor Relations & Filings

Ticker · HERANBA ISIN · INE694N01015 LEI · 335800OPXIEPYCNRWS37 BSE.NS Manufacturing
Open in API
Filings indexed 442 across all filing types
Latest filing 2025-11-05 Regulatory Filings
Country IN India
Listing BSE.NS HERANBA

About Heranba Industries Limited

https://www.heranba.co.in/

Heranba Industries Limited specializes in the manufacturing and marketing of synthetic pyrethroids and their intermediates. The company operates an integrated business model spanning the production of technicals, formulations, and branded products. Its extensive portfolio includes key active ingredients such as Cypermethrin, Deltamethrin, Alpha Cypermethrin, and Permethrin, catering to agriculture, public health, and animal health sectors. With multiple manufacturing facilities and dedicated R&D capabilities, the company provides a wide range of insecticides, herbicides, and fungicides. Heranba maintains a global footprint, supplying products to over sixty countries while ensuring quality control from intermediate stages to final crop protection solutions.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges about an upcoming Board Meeting scheduled for November 14, 2025. The purpose of the meeting includes considering and approving unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. The document also mentions compliance with SEBI regulations and insider trading rules. The document does not contain actual financial results or detailed financial data but is an announcement of the meeting where such results will be considered and approved. The document length is short (1793 characters), and it serves as an intimation or notice rather than a report or financial statement. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-11-05 English
Resignation
Regulatory Filings
2025-10-16 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document text is extremely short (365 characters) and contains only a digital signature with no substantive content or financial data. There is no indication of any report, announcement, or detailed information. It does not fit any specific report category and appears to be a minimal filing or certification. According to the rules, such minimal or certification-like documents should be classified as Regulatory Filings (RNS).
2025-10-10 English
Resignation
Regulatory Filings
2025-10-07 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the closure of the trading window for insiders ahead of the announcement of unaudited financial results for the quarter ended September 30, 2025. It references compliance with SEBI (Prohibition of Insider Trading) Regulations and informs about the trading restrictions period but does not contain any financial data or results itself. The document is short (1678 characters) and serves as an announcement related to regulatory compliance and trading restrictions, not a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other specific categories.
2025-09-27 English
Shareholders meeting
Regulatory Filings
2025-09-26 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.